⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5922399 | 0.75 | — | — | |
| SCHEMBL5149182 | 0.73 | — | — | |
| SCHEMBL16860536 | 0.69 | — | — | |
| SCHEMBL11861597 | 0.69 | — | — | |
| SCHEMBL988807 | 0.69 | — | — | |
| SCHEMBL7060291 | 0.68 | — | — | |
| SCHEMBL4626556 | 0.65 | — | — | |
| SCHEMBL29244226 | 0.65 | — | — | |
| SCHEMBL21689962 | 0.64 | — | — | |
| SCHEMBL9746255 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101215277-A | Two anticancer medicine raw material compounds | NAN ZHANG (CN) | 2008-07-09 | — | — | CN | claimed |
| CN-101104611-A | 3-methoxylflavonoid compound, preparation method and application thereof | ZHENGFENG YIN (CN) | 2008-01-16 | — | — | CN | claimed |
| CN-105744936-B | Substituted quinolizine derivatives useful as HIV integrase inhibitors | 默沙东公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-109923110-A | Bryostatin compound and preparation method | 小利兰·斯坦福大学托管委员会 | 2019-06-21 | — | — | CN | disclosed |
| CN-107012022-A | PERFUME SYSTEMS | 宝洁公司 | 2017-08-04 | — | — | CN | disclosed |
| CN-105744936-A | Substituted quinolizine derivatives useful as HIV integrase inhibitors | 默沙东公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-101703499-B | Two chemical anti-tumor drugs | NAN ZHANG | 2012-04-25 | — | — | CN | disclosed |
| CN-101952234-A | Phenyl-prenyl derivatives of marine and synthetic origin for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders | NOSCIRA SA | 2011-01-19 | — | — | CN | disclosed |
| CN-101703499-A | Two chemical antitumor drugs | NAN ZHANG | 2010-05-12 | — | — | CN | disclosed |
| CN-101215277-A | Two anticancer medicine raw material compounds | NAN ZHANG (CN) | 2008-07-09 | — | — | CN | disclosed |
| CN-101104611-A | 3-methoxylflavonoid compound, preparation method and application thereof | ZHENGFENG YIN (CN) | 2008-01-16 | — | — | CN | disclosed |
| WO-2006040644-A2 | PROCESSES FOR THE PREPARATION OF SUBSTITUTED THIOCHROMAN DERIVATIVES | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-20 | — | — | WO | disclosed |
| EP-0709392-B1 | Process for the preparation of 3-halogeno- or -pseudohalogeno-alkylsilane esters, respectively | DEGUSSA (DE) | 2001-05-16 | — | — | EP | disclosed |
| US-6060325-A | Detection and monitoring of toxic halogenated compounds | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 2000-05-09 | — | — | US | disclosed |
| EP-0908925-A2 | Determining halogen toxicity level of halogenated compounds | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1999-04-14 | — | — | EP | disclosed |
| US-5616762-A | Process for the preparation of 3-halo-and pseudohalo-alkylsilane esters | HUELS AKTIENGESELLSCHAFT (DE) | 1997-04-01 | — | — | US | disclosed |
| EP-0709392-A1 | Process for the preparation of 3-halogeno- or -pseudohalogeno-alkylsilane esters, respectively | HÜLS AKTIENGESELLSCHAFT (DE) | 1996-05-01 | — | — | EP | disclosed |